Arcturus Therapeutics Holdings Inc.
ARCT
$14.74
-$0.89-5.69%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -23.79M | -26.96M | -29.08M | -13.45M | -9.18M |
| Total Depreciation and Amortization | 643.00K | 658.00K | 682.00K | 763.00K | 779.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.29M | 4.29M | 8.78M | 5.90M | 6.33M |
| Change in Net Operating Assets | -1.06M | 2.57M | 3.39M | -10.37M | -3.68M |
| Cash from Operations | -19.91M | -19.44M | -16.23M | -17.15M | -5.76M |
| Capital Expenditure | -- | -- | 88.00K | -181.00K | 0.00 |
| Sale of Property, Plant, and Equipment | 18.00K | 34.00K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 18.00K | 34.00K | 88.00K | -181.00K | 0.00 |
| Total Debt Issued | -- | -- | 0.00 | 0.00 | 0.00 |
| Total Debt Repaid | -- | -- | 0.00 | 0.00 | -15.00M |
| Issuance of Common Stock | 0.00 | 16.00K | 11.69M | 1.23M | 274.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 0.00 | 16.00K | 11.69M | 1.23M | -14.73M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -19.89M | -19.39M | -4.45M | -16.11M | -20.48M |